HCPCS J2919: Methylprednisolone Sodium Succinate Injection, 5 mg

HCPCS Level II code J2919 denotes an injection of methylprednisolone sodium succinate, 5 mg — a short-acting systemic corticosteroid formulation used in various inflammatory and allergic conditions. Nationally, accurate coding for injectable corticosteroids matters for claims adjudication, drug utilization monitoring, and cost management across outpatient and office-based care.

This publication covers coverage and billing considerations for major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how the code is used in practice, typical sites of service, and common billing contexts. The analysis highlights benchmark metrics, payer policy nuances, and clinical context relevant to coding and claim submission.

The report provides practical reference material including reimbursement benchmark ranges where available, common billing scenarios, and recent policy updates affecting injectable corticosteroid claims. Clinical context outlines typical indications for methylprednisolone injections and considerations that affect coding specificity. Data not available in the input is clearly identified and omitted. This resource is intended for billing managers, practice administrators, and policy analysts working with outpatient drug injection claims.

Billing Code Overview

HCPCS Level II code J2919 represents an injection of methylprednisolone sodium succinate, 5 mg. This code describes a specific drug dosage administered by injection.

Service Type: Drug injection / parenteral drug administration

Typical Site of Service: Outpatient clinic, physician office, or outpatient hospital setting

Data not available in the input.

Clinical Context

A typical patient is an adult presenting to an outpatient clinic, urgent care, or emergency department with acute or chronic inflammatory conditions such as severe allergic reaction, asthma exacerbation, acute gout flare, or inflammatory musculoskeletal pain. The clinician prescribes a parenteral corticosteroid and administers J2919 (methylprednisolone sodium succinate, 5 mg) as an intramuscular or intravenous injection. The clinical workflow includes assessment of indication and allergies, informed consent, preparation of the correct dose (multiple units of J2919 may be billed to reach the ordered milligram dose), administration via IM or IV depending on urgency and venous access, post‑injection observation for adverse reactions, and documentation of drug name, dose, route, lot number, expiration, and patient tolerance. Typical sites of service are outpatient clinic, outpatient infusion center, emergency department, urgent care, and inpatient bedside for hospitalized patients requiring parenteral corticosteroid therapy.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management (E/M) service on the same day	Use when an E/M service is performed and documented on the same day as the injection and is above and beyond the usual preprocedure work

Taxonomy Code	Specialty	Notes
`207L00000X`	Physical Medicine & Rehabilitation Physician	Often administers corticosteroid injections for musculoskeletal and pain conditions
`207P00000X`	Anesthesiology	Manages injections for pain procedures and perioperative steroid use
`208D00000X`	Emergency Medicine Physician	Administers IV/IM methylprednisolone for acute allergic or respiratory emergencies
`207K00000X`	Family Medicine Physician	Commonly provides outpatient steroid injections for acute and chronic conditions
`207Q00000X`	Internal Medicine Physician	Provides inpatient and outpatient parenteral corticosteroid therapy

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J45.901`	Unspecified asthma, uncomplicated	IV or IM methylprednisolone used for acute asthma exacerbation
`T78.2XXA`	Anaphylactic shock, unspecified, initial encounter	Parenteral corticosteroid administered as part of acute allergic reaction management
`M10.071`	Acute gout attack, right ankle and foot	Corticosteroid injection considered when oral therapy is contraindicated or ineffective
`M25.561`	Pain in right knee	Intra‑articular corticosteroid injection for inflammatory knee pain
`M54.5`	Low back pain	Parenteral corticosteroid used for acute radicular or inflammatory presentations
`J96.00`	Acute respiratory failure, unspecified whether with hypoxia or hypercapnia	Systemic IV steroid therapy as part of respiratory failure treatment

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used when methylprednisolone (`J2919`) is administered intramuscularly in outpatient or clinic settings
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when IV methylprednisolone is given as a short infusion rather than bolus injection
`36415`	Collection of venous blood by venipuncture	Performed prior to IV therapy in some cases (e.g., labs before steroid administration)
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, low to moderate complexity	Typical E/M code when counseling and decision to administer injection occurs during an office visit
`96379`	Unlisted therapeutic, prophylactic, or diagnostic IV or IM injection/infusion	Used for injections or infusions not accurately described by other codes when billing for administration nuances

OpenPayer

Summary & Overview